on 25 May 2021
Last Applicant/ Owned by
Lucida Medical Ltd
ALLIA FUTURE BUSINESS CENTRE, KING’S HEDGES ROAD
Cambridge, , CB4 2HY
Serial Number
UK00003646579 filed on 25th May 2021
Registration Number
UK00003646579 registered on
29th Oct 2021
Correspondent Address
9 Hills Rd
Cambridge,
CB2 1GE
Downloadable software; Downloadable software for medical diagnostic services; Downloadable software in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Downloadable software for screening cancer; Downloadable software for detecting cancer Downloadable software for diagnosing cancer; Downloadable software for screening, detecting and diagnosing prostate cancer; Downloadable data analysis software; Downloadable data analysis software for screening, detecting and diagnosing cancer; Downloadable data analysis software for screening, detecting and diagnosing prostate cancer; Downloadable data processing software; Downloadable data processing software for screening, detecting and diagnosing cancer; Downloadable data processing software for screening, detecting and diagnosing prostate cancer; Downloadable machine learning software; Downloadable machine learning software for screening, detecting and diagnosing cancer; Downloadable machine learning software for screening, detecting and diagnosing prostate cancer; Downloadable artificial intelligence software; Downloadable artificial intelligence software for screening, detecting and diagnosing cancer; Downloadable artificial intelligence software for screening, detecting and diagnosing prostate cancer; Downloadable software for MRI machines; Downloadable software for medical apparatus; Downloadable software for medical imaging apparatus; Downloadable publications; Downloadable publications in the field of cancer, cancer research, cancer screening, cancer diagnosis, cancer treatment, MRI, MRI machines and medical imaging; .
Software as a service (SaaS); Platform as a service (PaaS); Design and development of software; Software as a service (SaaS) in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Software as a service (SaaS) for screening, detecting and diagnosing cancer; Software as a service (SaaS) for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) for data analysis; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) for data processing; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of machine learning software; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of artificial intelligence software; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) for MRI machines; Software as a service (SaaS) for medical imaging apparatus; Platform as a service (PaaS) in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Platform as a service (PaaS) for screening, detecting and diagnosing cancer; Platform as a service (PaaS) for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) for data analysis; Platform as a service (PaaS) in the nature of data analysis platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data analysis platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) for data processing; Platform as a service (PaaS) in the nature of data processing platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data processing platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of machine learning platform; Platform as a service (PaaS) in the nature of machine learning platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of machine learning platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of artificial intelligence platform; Platform as a service (PaaS) in the nature of artificial intelligence platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of artificial intelligence platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) for MRI machines; Platform as a service (PaaS) for medical imaging apparatus; Design and development of software in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Design and development of software for screening, detecting and diagnosing cancer; Design and development of software for screening, detecting and diagnosing prostate cancer; Design and development of data analysis software; Design and development of data analysis software for screening, detecting and diagnosing cancer; Design and development of data analysis software for screening, detecting and diagnosing prostate cancer; Design and development of data processing software; Design and development of data processing software for screening, detecting and diagnosing cancer; Design and development of data processing software for screening, detecting and diagnosing prostate cancer; Design and development of machine learning software; Design and development of machine learning software for screening, detecting and diagnosing cancer; Design and development of machine learning software for screening, detecting and diagnosing prostate cancer; Design and development of artificial intelligence software; Design and development of artificial intelligence software for screening, detecting and diagnosing cancer; Design and development of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Design and development of software for MRI machines; Design and development of software for medical imaging apparatus; Scientific research services; Scientific research services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Scientific research services in the field of artificial intelligence and machine learning; Testing of computer software; Information and advisory services relating to the aforementioned.
Provision of medical information; Provision of information in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Medical services; Healthcare services; Medical analysis services; Medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of prostate cancer; Medical diagnostic services; Medical diagnostic services for cancer; Medical diagnostic services for prostate cancer; Medical consulting services; Medical consulting services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Collation of information in the healthcare sector; Information and advisory services relating to the aforementioned.
UK00003646579
Word
Individual